Overview A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843 Status: Not yet recruiting Trial end date: 2022-02-18 Target enrollment: Participant gender: Summary A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843 Phase: Phase 1 Details Lead Sponsor: Chong Kun Dang Pharmaceutical